<PAGE> 1
FILED BY PHARMACIA & UPJOHN, INC.
PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933
SUBJECT COMPANY: PHARMACIA & UPJOHN, INC.
COMMISSION FILE NO. 001-11557
The following is an English translation of a press release issued in Sweden on
March 27, 2000, by Pharmacia & Upjohn, Inc., a Delaware corporation:
PRESS RELEASE
Monday, March 27, 2000
LISTING OF PHARMACIA CORPORATION ON THE OM STOCKHOLM EXCHANGE
Following the shareholders' approval of the merger between Pharmacia & Upjohn,
Inc. and Monsanto Company on March 23, the two companies expect that the merger
will conclude on or before April 1, 2000. As previously announced, this is
pending on EU-approval, which is expected on Thursday March 30.
Subject to the relevant EU approval being granted on March 30, the last trading
day for SDRs representing shares in Pharmacia & Upjohn on the OM Stockholm
Exchange is expected to be Friday March 31, 2000, whereas trading in SDRs
representing shares in the new company, Pharmacia Corporation, will commence on
Monday, April 3, 2000. The ISIN code for SDRs in Pharmacia Corporation will be
SE0000634040. The new ticker symbol will be PHA.
Settlement of transactions in SDRs in Pharmacia Corporation made on the OM
Stockholm Exchange on April 3 is expected to take place on April 7, i.e. after
four business days. Settlement of transactions made after April 3 is expected to
take place after three business days.
As previously announced the waiting period under US antitrust legislation, known
as the Hart-Scott-Rodino Act, expired on February 18.
MEDIA CONTACT:
Marianne Baarnhielm, Pharmacia & Upjohn AB
Tel. 08-695 72 82,
Mobile 070-319 50 60
ANALYST CONTACT:
Craig Tooman
Tel +1(908) 901-8853
<PAGE> 2
****************
Monsanto Company and Pharmacia & Upjohn, Inc. have filed a definitive joint
proxy statement/prospectus and other relevant documents concerning the
merger with the SEC. WE URGE INVESTORS TO READ THE DEFINITIVE JOINT PROXY
STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC,
BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors will be able to obtain
the documents free of charge at the SEC's Website, www.sec.gov.
In addition, the Form 10-K and other documents filed with the SEC by Monsanto
will be available free of charge from the Secretary of Monsanto at 800 North
Lindbergh Blvd., St. Louis, Missouri 63167, Telephone (314) 694-3155. The Form
10-K and other documents filed with the SEC by Pharmacia & Upjohn will be
available free of charge from the Corporate Secretary of Pharmacia & Upjohn, 100
Route 206 North, Peapack, NJ 07977, Telephone (888) 768-5501. READ THE
DEFINITIVE JOINT PROXY STATEMENT/ PROSPECTUS CAREFULLY.
